phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with glutamyl-glycyl-arginine chloromethyl ketone in 1 studies
Studies (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Trials (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Recent Studies (post-2010) (phenylalanyl-prolyl-arginine-chloromethyl ketone) | Studies (glutamyl-glycyl-arginine chloromethyl ketone) | Trials (glutamyl-glycyl-arginine chloromethyl ketone) | Recent Studies (post-2010) (glutamyl-glycyl-arginine chloromethyl ketone) |
---|---|---|---|---|---|
191 | 4 | 23 | 5 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drobot, DW; Harding, SR; Lyon, AW; Lyon, ME | 1 |
1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and glutamyl-glycyl-arginine chloromethyl ketone
Article | Year |
---|---|
Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) as anticoagulants for critical care clinical chemistry spe
Topics: Amino Acid Chloromethyl Ketones; Anticoagulants; Antithrombins; Artifacts; Critical Care; Drug Evaluation; Factor Xa Inhibitors; Humans; Specimen Handling | 1999 |